Relationship between HLA-G gene polymorphism and the susceptibility of esophageal cancer in Kazakh and Han nationality in Xinjiang

Biomarkers

Volumn 17, Issue 1, 2012, Pages 9-15

  Chen, Yan ^a   Gao, Xiu Jing ^a   Deng, Yan Chao ^a   Zhang, Hui Xia ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; Genetic polymorphism; Human 8 hydroxyguanine glycosylase; Kazakh

Indexed keywords

HLA G ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ESOPHAGUS CANCER; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE DELETION;

EID: 84863047807     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.633242     Document Type: Article

References (30)

1. Barrier BF, Kendall BS, Sharpe-Timms KL, Kost ER. (2006). Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 103:25-30. (Pubitemid 44389864)
2. Castelli EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA. (2008). HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 72:149-157. (Pubitemid 352009823)
3. Carosella ED, Horuzsko A. (2007). HLA-G and cancer. Semin Cancer Biol 17:411-412. (Pubitemid 350052591)
4. Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, LeMaoult J. (2007). Trogocytosis-based generation of suppressive NK cells. EMBO J 26:1423-1433. (Pubitemid 46398697)
5. Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, Zhang X, Cao FL, Zhang JG, Yan WH. (2010). Upregulation of human leukocyte antigen-G expression and its clinical signifcance in ductal breast cancer. Hum Immunol 71:892-898.
6. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. (2008). Te 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72:335-341.
7. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F. (2003). Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33:125-134. (Pubitemid 36157650)
8. Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B. (2008). Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens 72:137-148. (Pubitemid 352009822)
9. Dunn GP, Koebel CM, Schreiber RD. (2006). Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836-848. (Pubitemid 44631652)
10. Dunn GP, Old LJ, Schreiber RD. (2004). Te three Es of cancer immunoediting. Annu Rev Immunol 22:329-360.
11. Hviid TV. (2006). HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 12:209-232.
12. Lajoie J, Massinga Loembe M, Poudrier J, Guédou F, Pépin J, Labbé AC, Alary M, Roger M. (2010). Blood soluble human leukocyte antigen G levels are associated with human immunodefciency virus type 1 infection in Beninese commercial sex workers. Hum Immunol 71:182-185.
13. La Nasa G, Littera R, Locatelli F, Lai S, Alba F, Caocci G, Lisini D, Nesci S, Vacca A, Piras E, Bernardo ME, Di Cesare-Merlone A, Orru S, Carcassi C. (2007). Te human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol 139:284-288 (Pubitemid 47493086)
14. Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P. (2002). Specifc activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196:266-274. (Pubitemid 34189414)
15. Le Discorde M, Le Danf C, Moreau P, Rouas-Freiss N, Carosella ED. 2005 HLA-G*0105N null allele encodes functional HLA-G isoforms. Biol Reprod 73, 280-288. (Pubitemid 41022787)
16. LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A, Carosella ED. 2007, Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make efector T cells act as regulatory cells. Blood 109, 2040-2048. (Pubitemid 46348204)
17. Lin A, Li M, Xu DP, Zhang WG, Yan WH. (2009). Ethnic variation of the HLA-G*0105N allele in two Chinese populations. Tissue Antigens 73:270-274.
18. Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M. (2004). Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 18:427-431. (Pubitemid 38365869)
19. Martinetti M, Pacati I, Cuccia M, Badulli C, Pasi A, Salvaneschi L, Minola E, De Silvestri A, Iannone AM, Maccabruni A. (2006). Hierarchy of baby-linked immunogenetic risk factors in the HLA-G polymorphisms and functional implications 393 vertical transmission of hepatitis C virus. Int J Immunopathol Pharmacol 19:369-378. (Pubitemid 44181959)
20. Menier C, Prevot S, Carosella ED, Rouas-Freiss N. (2009). Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology. Hum Immunol 70:1006-1009.
21. Miller SA, Dykes DD, Polesky HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
22. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, Moreau P. (2001). Altered HLA-G transcription in pre-eclampsia is associated with allele specifc inheritance: Possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 58:1943-1949. (Pubitemid 33108779)
23. Pyo CW, Williams LM, Moore Y, Hyodo H, Li SS, Zhao LP, Sageshima N, Ishitani A, Geraghty DE. (2006). HLA-E, HLA-F, and HLA-G polymorphism: Genomic sequence defnes haplotype structure and variation spanning the nonclassical class I genes. Immunogenetics 58:241-251. (Pubitemid 43673468)
24. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. (2005). Tolerization of dendritic cells by HLA-G. Eur J Immunol 35:1133-1142. (Pubitemid 40542220)
25. Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, Stignani M, Carturan S, Grappa MT, Fotinidi M, Ferretti S, Voss A, Laustrup H, Junker P, Trotta F, Baricordi OR. (2008). HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71:520-529. (Pubitemid 351697240)
26. Rouas-Freiss N, Moreau P, Menier C, Carosella ED. 2003 HLA-G in cancer: A way to turn of the immune system. Semin Cancer Biol 13, 325-336. (Pubitemid 38160931)
27. Tripathi P, Abbas A, Naik S, Agrawal S. (2004). Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 64:706-710. (Pubitemid 39628052)
28. Veit TD, Chies JAB. (2008). Tolerance versus immune response-MicroRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 11:1-3.
29. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. (2007). Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 128:1002-1009.
30. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. (2007). Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 14: 2721-2729. (Pubitemid 47460633)